USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ARIZONA CANCER THERAPEUTICS, LLC
Address:
5540 E PASEO CIMARRON
TUCSON, AZ 85750-1101
Phone:
N/A
URL:
N/A
EIN:
145392995
DUNS:
21115879
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $300,000.00 1

Award List:

Decoy Peptides: Development of a Novel Therapeutic for Metastatic Cancer

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Todd D. Camenisch – 520-955-1948
Research Institution:
UNIVERSITY OF ARIZONA
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Arizona Cancer Therapeutics LLC (ACT) proposes a two-year, preclinical research project in cooperation with the University of Arizona Cancer Center to develop the novel anti-tumor therapeutic, Protein transduction domain-MUC1 Inhibitory Peptide (PMIP). PMIP is an… More